Kayla A. Chase, Ph.D. - Related publications

University of Illinois at Chicago, Chicago, IL, United States 
Epigenetics, Schizophrenia
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
42 most relevant papers in past 60 days:
Year Citation  Score
2021 Barros C, Silva CA, Pinheiro AP. Advanced EEG-based learning approaches to predict schizophrenia: Promises and pitfalls. Artificial Intelligence in Medicine. 114: 102039. PMID 33875158 DOI: 10.1016/j.artmed.2021.102039   
2021 Brandt SJ, Oral HY, Arellano-Bravo C, Plawecki MH, Hummer TA, Francis MM. Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33844154 DOI: 10.1007/s13311-021-01046-1   
2021 Zhao N, Wang XH, Kang CY, Zheng Y, Yang LY, Guan TF, Bai YX, Wei R, Hinman HC, Zhang XY. Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia. Annals of General Psychiatry. 20: 26. PMID 33882965 DOI: 10.1186/s12991-021-00347-1   
2021 Plana-Ripoll O, Di Prinzio P, McGrath JJ, Mortensen PB, Morgan VA. Factors that contribute to urban-rural gradients in risk of schizophrenia: Comparing Danish and Western Australian registers. The Australian and New Zealand Journal of Psychiatry. 48674211009615. PMID 33985345 DOI: 10.1177/00048674211009615   
2021 Zhang Z, Zhuo K, Xiang Q, Sun Y, Suckling J, Wang J, Liu D, Sun Y. Dynamic functional connectivity and its anatomical substrate reveal treatment outcome in first-episode drug-naïve schizophrenia. Translational Psychiatry. 11: 282. PMID 33980821 DOI: 10.1038/s41398-021-01398-4   
2021 Yu JJ, Zhao Q, Li HN, Song JQ, Chen DC. Macrophage migration inhibitory factor as a potential novel biomarker for cognitive function in patients with first-episode schizophrenia. The Australian and New Zealand Journal of Psychiatry. 48674211013086. PMID 33985351 DOI: 10.1177/00048674211013086   
2021 Yang M, Jia X, Zhou H, Ren P, Deng H, Kong Z, Xie C, Hu W, Jiang W, Lai W, Zhang B, Zhao M, Liu T. Brain dysfunction of methamphetamine-associated psychosis in resting state: Approaching schizophrenia and critical role of right superior temporal deficit. Addiction Biology. e13044. PMID 33957703 DOI: 10.1111/adb.13044   
2021 Dong R, Zhao NO, Wu HE, Yu L, Zhang XY. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics. Journal of Psychiatric Research. 138: 492-499. PMID 33971483 DOI: 10.1016/j.jpsychires.2021.04.026   
2021 Wu Q, Huang J, Wu R. Drugs Based on NMDAR Hypofunction Hypothesis in Schizophrenia. Frontiers in Neuroscience. 15: 641047. PMID 33912003 DOI: 10.3389/fnins.2021.641047   
2021 Hájková M, Knížková K, Siroňová A, Keřková B, Jonáš J, Šustová P, Dorazilová A, Rodriguez M. Cognitive performance and lifetime cannabis use in patients with first-episode schizophrenia spectrum disorder. Cognitive Neuropsychiatry. 1-16. PMID 33973827 DOI: 10.1080/13546805.2021.1924649   
2021 Akamine Y, Kikuchi Y, Miura M. Effects on monotherapy and reduction of antipsychotic drugs by clozapine therapy in Japanese patients with treatment-resistant schizophrenia. Journal of Clinical Pharmacy and Therapeutics. PMID 33959995 DOI: 10.1111/jcpt.13432   
2021 Joung J, Kim B, Kim J, Lee G, Kim S. "Moving forward despite adversity": The lives of Korean older adults with schizophrenia. Archives of Psychiatric Nursing. 35: 243-249. PMID 33966787 DOI: 10.1016/j.apnu.2021.02.005   
2021 Livingston NR, Hawkins PC, Gilleen J, Ye R, Valdearenas L, Shergill SS, Mehta MA. Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia. Journal of Psychopharmacology (Oxford, England). 2698811211000778. PMID 33908296 DOI: 10.1177/02698811211000778   
2021 Sarkar S, Rajalakshmi AR, Avudaiappan S, Eswaran S. Exploring the role of macular thickness as a potential early biomarker of neurodegeneration in acute schizophrenia. International Ophthalmology. PMID 33856596 DOI: 10.1007/s10792-021-01831-z   
2021 Merritt K, McGuire PK, Egerton A, , Aleman A, Block W, Bloemen OJN, Borgan F, Bustillo JR, Capizzano AA, Coughlin JM, De la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, et al. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. Jama Psychiatry. PMID 33881460 DOI: 10.1001/jamapsychiatry.2021.0380   
2021 Hakami T, Mahmoud M, Mohammed B, El-Setouhy M. Effects of khat use on response to antipsychotic medications in patients with newly diagnosed schizophrenia: a retrospective study. Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. 27: 353-360. PMID 33955531 DOI: 10.26719/emhj.21.003   
2021 Schoonover KE, Kennedy WM, Roberts RC. Cortical copper transporter expression in schizophrenia: interactions of risk gene dysbindin-1. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 33890175 DOI: 10.1007/s00702-021-02333-z   
2021 Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, et al. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. The American Journal of Psychiatry. appiajp202020081212. PMID 33985348 DOI: 10.1176/appi.ajp.2020.20081212   
2021 Aguilar DD, Radzik LK, Schiffino FL, Folorunso OO, Zielinski MR, Coyle JT, Balu DT, McNally JM. Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction. Scientific Reports. 11: 9031. PMID 33907230 DOI: 10.1038/s41598-021-88428-9   
2021 Kim BH, Kim HE, Lee JS, Kim JJ. Anhedonia Relates to the Altered Global and Local Grey Matter Network Properties in Schizophrenia. Journal of Clinical Medicine. 10. PMID 33807226 DOI: 10.3390/jcm10071395   
2021 Marques TR, Veronese M, Owen DR, Rabiner EA, Searle GE, Howes OD. Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33825022 DOI: 10.1007/s00259-021-05327-x   
2021 Barnes-Scheufler CV, Passow C, Rösler L, Mayer JS, Oertel V, Kittel-Schneider S, Matura S, Reif A, Bittner RA. Transdiagnostic comparison of visual working memory capacity in bipolar disorder and schizophrenia. International Journal of Bipolar Disorders. 9: 12. PMID 33797645 DOI: 10.1186/s40345-020-00217-x   
2021 Cervello S, Dubreucq J, Trichanh M, Dubrulle A, Amado I, Bralet MC, Chirio-Espitalier M, Delille S, Fakra E, Francq C, Guillard-Bouhet N, Graux J, Lançon C, Zakoian JM, Gauthier E, et al. Cognitive remediation and professional insertion of people with schizophrenia: RemedRehab, a randomized controlled trial. European Psychiatry : the Journal of the Association of European Psychiatrists. 64: e31. PMID 33853701 DOI: 10.1192/j.eurpsy.2021.25   
2021 Heller C, Weiss T, Del Re EC, Swago S, Coman IL, Antshel KM, Fremont W, Bouix S, Kates WR, Kubicki MR, Kikinis Z. Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia. Psychiatry Research. 301: 113979. PMID 33993037 DOI: 10.1016/j.psychres.2021.113979   
2021 Ochiai H, Shiga T, Hoshino H, Horikoshi S, Kanno K, Wada T, Osakabe Y, Miura I, Yabe H. Effect of oxytocin nasal spray on auditory automatic discrimination measured by mismatch negativity. Psychopharmacology. PMID 33829308 DOI: 10.1007/s00213-021-05807-w   
2021 Xie YJ, Xi YB, Cui LB, Guan MZ, Li C, Wang ZH, Fang P, Yin H. Functional connectivity of cerebellar dentate nucleus and cognitive impairments in patients with drug-naive and first-episode schizophrenia. Psychiatry Research. 300: 113937. PMID 33895443 DOI: 10.1016/j.psychres.2021.113937   
2021 Iyo M, Ishigooka J, Nakamura M, Sakaguchi R, Okamoto K, Mao Y, Tsai J, Fitzgerald A, Nosaka T, Higuchi T. Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study. Psychiatry and Clinical Neurosciences. PMID 33890388 DOI: 10.1111/pcn.13221   
2021 Thomas MB, Raghava JM, Pantelis C, Rostrup E, Nielsen MØ, Jensen MH, Glenthøj BY, Mandl RCW, Ebdrup BH, Fagerlund B. Associations between cognition and white matter microstructure in first-episode antipsychotic-naïve patients with schizophrenia and healthy controls: A multivariate pattern analysis. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 139: 282-297. PMID 33933719 DOI: 10.1016/j.cortex.2021.03.003   
2021 Shah R, Ghosh A, Avasthi A, Nehra R, Ahuja CK, Khandelwal N. Do neurocognitive functions in cannabis induced psychosis groups differ from schizophrenia with cannabis use? A controlled cross-sectional study. International Journal of Psychiatry in Clinical Practice. 1-9. PMID 33856944 DOI: 10.1080/13651501.2021.1912356   
2021 Hare SM, Du X, Adhikari BM, Chen S, Mo C, Summerfelt A, Kvarta MD, Garcia L, Kochunov P, Elliot Hong L. Mapping local and long-distance resting connectivity markers of TMS-related inhibition reduction in schizophrenia. Neuroimage. Clinical. 31: 102688. PMID 33991855 DOI: 10.1016/j.nicl.2021.102688   
2021 Ramsay IS, Fryer S, Roach BJ, Boos A, Fisher M, Loewy R, Ford JM, Vinogradov S, Mathalon DH. Response to targeted cognitive training may be neuroprotective in patients with early schizophrenia. Psychiatry Research. Neuroimaging. 312: 111285. PMID 33865147 DOI: 10.1016/j.pscychresns.2021.111285   
2021 Suttkus S, Schumann A, de la Cruz F, Bär KJ. Working memory in schizophrenia: The role of the locus coeruleus and its relation to functional brain networks. Brain and Behavior. e02130. PMID 33784023 DOI: 10.1002/brb3.2130   
2021 Klaus F, Mitchell K, Liou SC, Eyler LT, Nguyen TT. Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis. Journal of Psychiatric Research. 138: 139-145. PMID 33852994 DOI: 10.1016/j.jpsychires.2021.04.007   
2021 Siddiqui SV, Nizamie SH, Siddiqui MA, Jahan M, Garg S, Tikka SK, Shreekantiah U. Evaluation of N-400 Evoked Response Potential in schizophrenia: An endophenotype or a disease marker? Psychiatry Research. 300: 113907. PMID 33839423 DOI: 10.1016/j.psychres.2021.113907   
2021 Nakata Y, Kanahara N, Kimura A, Niitsu T, Komatsu H, Oda Y, Nakamura M, Ishikawa M, Hasegawa T, Kamata Y, Yamauchi A, Inazumi K, Kimura H, Shiko Y, Kawasaki Y, et al. Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR. Journal of Psychiatric Research. 138: 219-227. PMID 33866050 DOI: 10.1016/j.jpsychires.2021.03.053   
2021 Zhu R, Wang D, Wei G, Wang J, Zhou H, Xu H, Wang W, Wei S, Chen D, Xiu M, Wang L, Zhang XY. Association of negative symptoms with cognitive impairment in Chinese Han patients with chronic schizophrenia. International Journal of Psychiatry in Clinical Practice. 1-7. PMID 33879034 DOI: 10.1080/13651501.2021.1912357   
2021 Meiron O, David J, Yaniv A. Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia. Neuroscience Letters. 135912. PMID 33894334 DOI: 10.1016/j.neulet.2021.135912   
2021 Horne CM, Vanes LD, Verneuil T, Mouchlianitis E, Szentgyorgyi T, Averbeck B, Leech R, Moran RJ, Shergill SS. Cognitive control network connectivity differentially disrupted in treatment resistant schizophrenia. Neuroimage. Clinical. 30: 102631. PMID 33799270 DOI: 10.1016/j.nicl.2021.102631   
2021 Wang C, Oughourlian T, Tishler TA, Anwar F, Raymond C, Pham AD, Perschon A, Villablanca JP, Ventura J, Subotnik KL, Nuechterlein KH, Ellingson BM. Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia. Schizophrenia Research. 231: 179-188. PMID 33872855 DOI: 10.1016/j.schres.2021.04.001   
2021 Francis AM, Parks A, Choueiry J, El-Marj N, Impey D, Knott VJ, Fisher DJ. Sensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration. Psychopharmacology. PMID 33932162 DOI: 10.1007/s00213-021-05843-6   
2021 Cupo L, Plitman E, Guma E, Chakravarty MM. A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis. Translational Psychiatry. 11: 217. PMID 33850098 DOI: 10.1038/s41398-021-01295-w   
2021 Fish KN, Rocco BR, DeDionisio AM, Dienel SJ, Sweet RA, Lewis DA. Altered Parvalbumin Basket Cell Terminals in the Cortical Visuospatial Working Memory Network in Schizophrenia. Biological Psychiatry. PMID 33892915 DOI: 10.1016/j.biopsych.2021.02.009